Journal of Hepatology
Volume 39, Issue 2 , Pages 208-214 , August 2003

Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development

  • Mauro Borzio

      Affiliations

    • Department of Medicine, Gastroenterology Unit, Ospedale Fatebenefratelli, C.so Porta Nuova 23, 20121 Milan, Italy
    • Department of Pathology, Gastroenterology Unit, Ospedale Fatebenefratelli, C.so Porta Nuova 23, 20121 Milan, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39-2-6363-2596; fax: +39-2-6363-2665
    • ,
  • Silvia Fargion

      Affiliations

    • Department of Internal Medicine, Ospedale Maggiore IRCCS, Università di Milano, Milan, Italy
    • ,
  • Franco Borzio

      Affiliations

    • Department of Medicine, Gastroenterology Unit, Ospedale Fatebenefratelli, C.so Porta Nuova 23, 20121 Milan, Italy
    • Department of Pathology, Gastroenterology Unit, Ospedale Fatebenefratelli, C.so Porta Nuova 23, 20121 Milan, Italy
    • ,
  • Anna Ludovica Fracanzani

      Affiliations

    • Department of Internal Medicine, Ospedale Maggiore IRCCS, Università di Milano, Milan, Italy
    • ,
  • Anna Maria Croce

      Affiliations

    • Department of Medicine, Gastroenterology Unit, Ospedale Fatebenefratelli, C.so Porta Nuova 23, 20121 Milan, Italy
    • Department of Pathology, Gastroenterology Unit, Ospedale Fatebenefratelli, C.so Porta Nuova 23, 20121 Milan, Italy
    • ,
  • Tommaso Stroffolini

      Affiliations

    • Liver Unit, Ospedale San Giacomo, Rome, Italy
    • ,
  • Silvia Oldani

      Affiliations

    • Department of Medicine, Gastroenterology Unit, Ospedale Fatebenefratelli, C.so Porta Nuova 23, 20121 Milan, Italy
    • Department of Pathology, Gastroenterology Unit, Ospedale Fatebenefratelli, C.so Porta Nuova 23, 20121 Milan, Italy
    • ,
  • Rodolfo Cotichini

      Affiliations

    • Laboratory of Epidemiology, Istituto Superiore di Sanità, Rome, Italy
    • ,
  • Massimo Roncalli

      Affiliations

    • Department of Pathology, Istituto Clinico Humanitas, Rozzano, Università di Milano, Milan, Italy

Received 2 December 2002 ,Revised 27 March 2003 ,Accepted 9 April 2003.

References 

  1. Bruix J, Llovet MJ. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology. 2002;35:519–524
  2. International Working Party . Terminology of nodular lesions of the liver. Hepatology. 1995;22:983–993
  3. Theise N. Macroregenerative (Dysplastic) nodules and hepatocarcinogenesis: theoretical and clinical consideration. Sem Liver Dis. 1995;15:360–371
  4. Kondo F, Ebara M, Sugiura N, Wada K, Kita K, Hirooka N, et al.  Histological features and clinical course of large regenerative nodules: evaluation of their precancerous potentiality. Hepatology. 1990;12:592–598
  5. Takayama T, Makuuchi M, Hirohashi S, Sakamoto M, Okazaki N, Takayasu K, et al.  Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet. 1990;336:1150–1153
  6. Rapaccini L, Pompili M, Caturelli E, Anti M, Aliotta A, Cedrone A, et al.  Focal ultrasound lesions in liver cirrhosis diagnosed as regenerating nodules by fine-needle biopsy. Follow-up of 12 cases. Dig Dis Sci. 1990;35:422–427
  7. Seki S, Sakaguchi H, Kitada T, Tamori A, Takeda T, Kawada N, et al.  Outcomes of dysplastic nodules in human cirrhotic liver: a clinicopathological study. Clin Cancer Res. 2000;6:3469–3473
  8. Borzio M, Borzio F, Croce A, Sala M, Salmi A, Leandro G, et al.  Ultrasonography-detected macroregenerative nodules in cirrhosis: a prospective study. Gastroenterology. 1997;112:1617–1623
  9. Gibson JB, Sobin LH. Histological typing of tumors of the liver, biliary tract and pancreas. International histological classification of tumors, no. 20. Geneva: World Health Organization; 1978;
  10. Anthony PP, Vogel CL, Barker LF. Liver cell dysplasia: a premalignant condition. J Clin Pathol. 1973;26:217–223
  11. Watanabe S, Okita K, Harada T, Kodama T, Numa Y, Takemoto T, et al.  Morphologic studies of the liver cell dysplasia. Cancer. 1983;51:2197–2205
  12. Kaplan EL, Meier P. Non-parametric estimation for incomplete observation. J Am Stat Assoc. 1958;53:457–481
  13. Cox DR. Regression models and life tables. J R Stat Soc. 1972;34:187–220
  14. Colombo M, De Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, et al.  Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med. 1991;325:675–680
  15. Chiaramonte M, Stroffolini T, Vian A, Stazi MA, Floreani A, Lorenzoni U, et al.  Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer. 1999;85:2132–2137
  16. Terasaki S, Kanedo S, Kobayashi K, Nonamoura A, Nakanuma Y. Histological features predicting malignant transformation of non-malignant hepatocellular nodules: a prospective study. Gastroenterology. 1998;115:1216–1222
  17. Earls JP, Theise ND, Weinreb JC, DeCorato DR, Krinsky GA, Rofsky NM, et al.  Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation. Radiology. 1996;201:207–214
  18. Lim JH, Cho JM, Kim EY, Park CK. Dysplastic nodules in liver cirrhosis: evaluation of hemodynamics with CT during arterial portography and CT hepatic arteriography. Radiology. 2000;214:869–874
  19. Fracanzani AL, Burdick L, Borzio M, Roncalli M, Bonelli N, Borzio F, et al.  Contrast-enhanced doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis. Hepatology. 2001;34:1109–1112
  20. Park YN, Yang CP, Fernandez GJ, Cubukcu O, Thung S, Theise N. Neoangiogenesis and sinusoidal capillarization in dysplastic nodules of the liver. Am J Surg Pathol. 1998;22:656–662
  21. Roncalli M, Roz E, Coggi G, Di Rocco MG, Bossi P, Minola E, et al.  The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implication for diagnosis and classification. Hepatology. 1999;30:1174–1178
  22. Le Bail B, Bellannèe G, Bernard P-H, Saric J, Balabaud C, Bioulac-Sage P. Adenomatous hyperplasia in cirrhotic livers: histological evaluation, cellular density, and proliferative activity of 35 macronodular lesions in cirrhotic explants of 10 adult French patients. Hum Pathol. 1995;26:897–906
  23. Maggioni M, Coggi G, Cassani B, Bianchi P, Romagnoli S, Mandelli A, et al.  Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies. Hepatology. 2000;32:942–946
  24. Borzio M, Bruno S, Roncalli M, Colloredo Mels G, Ramella G, Borzio F, et al.  Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study. Gastroenterology. 1995;108:812–817
  25. Ganne-Carrié N, Chastang C, Chapel F, Munz C, Pateron D, Sibony M, et al.  Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis. Hepatology. 1996;23:1112–1118
  26. Lee RG, Tsamandas AC, Demetris AJ. Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched case-control study, pathological analysis, and pathogenetic hypothesis. Hepatology. 1997;26:1415–1422
  27. Fracanzani AL, Borzio M, Roncalli M, Derenzini M, Trerè D, Mattioli M, et al.  Can large cell change and high proliferative activity predict hepatocellular carcinoma in patients with hereditary hemochromatosis. Am J Gastroenterol. 2000;95:2940–2945

PII: S0168-8278(03)00190-9

doi: 10.1016/S0168-8278(03)00190-9

Journal of Hepatology
Volume 39, Issue 2 , Pages 208-214 , August 2003

Article Tools

* Image Usage & Resolution